Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Interaction Map Value Type description Rank Network Comparison Type Gene red Filtered green network_comparison
Results: HTML CSV LaTeX Showing element 1051 to 1100 of 3228 in total 
Interaction Map: High confidence
Value Type: Measured
Network Comparison Type: Divided
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fos-related antigen 1 (fra-1). [source:swissprot;acc:p15407]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
87\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4944.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7038.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.42347\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fos-related antigen 2. [source:swissprot;acc:p15408]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
85\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4941.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7037.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.42395\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fragile x mental retardation 1 protein (protein fmr-1) (fmrp). [source:swissprot;acc:q06787]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2431\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7242.75\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7508.98\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.03676\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fragile x mental retardation syndrome related protein 1. [source:swissprot;acc:p51114]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2429\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
7243.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7509.81\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.03681\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
fragile x mental retardation syndrome related protein 2. [source:swissprot;acc:p51116]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2428\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
frg1 protein (fshd region gene 1 protein). [source:swissprot;acc:q14331]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1926\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7260.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7711.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06213\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase (ec 3.1.3.11) (d-fructose-1,6-bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:p09467]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1036\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6077.65\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6649.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09404\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fructose-1,6-bisphosphatase isozyme 2 (ec 3.1.3.11) (d-fructose-1,6- bisphosphate 1-phosphohydrolase) (fbpase). [source:swissprot;acc:o00757]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1033\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6080.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6653.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09417\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fructose-bisphosphate aldolase a (ec 4.1.2.13) (muscle-type aldolase) (lung cancer antigen ny-lu-1). [source:swissprot;acc:p04075]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2907\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
fructose-bisphosphate aldolase b (ec 4.1.2.13) (liver-type aldolase). [source:swissprot;acc:p05062]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2973\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
fructose-bisphosphate aldolase c (ec 4.1.2.13) (brain-type aldolase). [source:swissprot;acc:p09972]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3087\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ftsj homolog 3; likely ortholog of mouse ectoplacental cone, invasive trophoblast giant cells, extraembryonic ectoderm and chorion sequence 3. [source:refseq;acc:nm\_017647]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
621\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4115.39\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4633.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.12601\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fumarate hydratase, mitochondrial precursor (ec 4.2.1.2) (fumarase). [source:swissprot;acc:p07954]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2726\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5332.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5351.72\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00351\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fuse binding protein 3 (fragment). [source:sptrembl;acc:q92946]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2093\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5817.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6138.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.05524\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fuse-binding protein-interacting repressor isoform b; siah binding protein 1; pyrimidine tract binding splicing factor; ro ribonucleoprotein-binding protein 1; poly-u binding splicing factor puf60. [source:refseq;acc:nm\_014281]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1590\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6364.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6819.38\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07155\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fused toes homolog; likely ortholog of mouse fused toes. [source:refseq;acc:nm\_022476]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1820\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5633.44\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5997\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.06454\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fyve-finger-containing rab5 effector protein rabenosyn-5. [source:refseq;acc:nm\_022340]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2998\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
fzr1 protein; fizzy-related protein; cdc20-like 1b. [source:refseq;acc:nm\_016263]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
733\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
13241.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
11864\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1161\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
g protein-coupled receptor 66. [source:refseq;acc:nm\_006056]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
2815\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
g-rich sequence factor-1 (grsf-1). [source:swissprot;acc:q12849]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1396\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5803.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6256.54\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07806\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
g1 to s phase transition protein 1 homolog (gtp-binding protein gst1-hs). [source:swissprot;acc:p15170]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1336\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6140.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6632.24\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08014\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
g2/mitotic-specific cyclin b1. [source:swissprot;acc:p14635]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
362\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12786.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10879.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17525\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
g2/mitotic-specific cyclin b2. [source:swissprot;acc:o95067]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
360\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
12796.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
10886\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.17553\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ga binding protein alpha chain (gabp-alpha subunit) (transcription factor e4tf1-60) (nuclear respiratory factor-2 subunit alpha). [source:swissprot;acc:q06546]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
455\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4890.51\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5610.95\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.14731\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ga binding protein beta-2 chain (gabp-beta-2 subunit) (transcription factor e4tf1-47) (gapbp-2) (nuclear respiratory factor-2 subunit gamma). [source:swissprot;acc:q06545]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
456\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gaba(a) receptor-associated protein; gaba(a)-receptor-associated protein. [source:refseq;acc:nm\_007278]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
133\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
23421.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
17580.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.33225\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gaba-a receptor-associated protein. [source:sptrembl;acc:q9by60]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
134\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
21785.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
16426.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.32626\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
galactose-1-phosphate uridylyltransferase (ec 2.7.7.12) (gal-1-p uridylyltransferase) (udp-glucose--hexose-1-phosphate uridylyltransferase). [source:swissprot;acc:p07902]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
517\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4910.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5600.61\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.14051\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
galectin-4 (lactose-binding lectin 4) (l-36 lactose binding protein) (l36lbp) (antigen ny-co-27). [source:swissprot;acc:p56470]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
966\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7817.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8575.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09686\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
galectin-9 (hom-hd-21) (ecalectin). [source:swissprot;acc:o00182]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
973\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
7810.11\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
8566.29\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09682\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma adducin (adducin-like protein 70). [source:swissprot;acc:q9uey8]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1365\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5799.14\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6255.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07862\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma enolase (ec 4.2.1.11) (2-phospho-d-glycerate hydro-lyase) (neural enolase) (nse) (enolase 2). [source:swissprot;acc:p09104]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
943\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6597.98\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
7241\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.09746\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-1 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p14867]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
587\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6739.83\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7644.63\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.13425\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-2 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p47869]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
580\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-3 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p34903]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
588\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-4 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p48169]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
584\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
6739.82\vspace{3pt}}}&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor alpha-6 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q16445]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
581\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor epsilon subunit precursor (gaba(a) receptor). [source:swissprot;acc:p78334]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
585\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-1 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q8n1c3]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
579\vspace{3pt}}&&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
7644.62\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-2 subunit precursor (gaba(a) receptor). [source:swissprot;acc:p18507]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
582\vspace{3pt}}&&&\\\cline{1-3}
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-aminobutyric-acid receptor gamma-3 subunit precursor (gaba(a) receptor). [source:swissprot;acc:q99928]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
577\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6739.81\vspace{3pt}}&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-butyrobetaine,2-oxoglutarate dioxygenase (ec 1.14.11.1) (gamma-butyrobetaine hydroxylase) (gamma-bbh). [source:swissprot;acc:o75936]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1348\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
6153.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6640.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07921\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-interferon inducible lysosomal thiol reductase precursor (gamma-interferon-inducible protein ip-30). [source:swissprot;acc:p13284]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
3101\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-sarcoglycan (gamma-sg) (35 kda dystrophin-associated glycoprotein) (35dag). [source:swissprot;acc:q13326]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
741\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5768.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6434.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.11554\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-snap-associated factor 1; rab11-interacting protein. [source:refseq;acc:nm\_015470]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1450\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5602.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6031.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.07659\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gamma-soluble nsf attachment protein (snap-gamma) (n-ethylmaleimide- sensitive factor attachment protein, gamma). [source:swissprot;acc:q99747]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
500\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4682.87\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4093.05\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.1441\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
ganglioside-induced differentiation-associated protein 1-like 1. [source:refseq;acc:nm\_024034]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
776\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
5874.76\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
6533.36\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.11211\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
ganglioside-induced differentiation-associated protein 1. [source:refseq;acc:nm\_018972]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
779\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gastricsin precursor (ec 3.4.23.3) (pepsinogen c). [source:swissprot;acc:p20142]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
1188\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4392.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4776.19\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.08732\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
23\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
699.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1894.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.7072\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/